Alembic Pharmaceuticals receives USFDA Final Approval for Vardenafil Hydrochloride Tablets

Alembic Pharmaceuticals Limited announced that the Company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vardenafil Hydrochloride Tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base).

source https://www.pharmatutor.org/pharma-news/2020/alembic-pharmaceuticals-receives-usfda-final-approval-for-vardenafil-hydrochloride-tablets